EndoPredict® personalizes your breast cancer treatment based on tailored results specific to your cancer
Confidently decide with your provider whether the benefits outweigh the risks of undergoing treatment with chemotherapy based on the aggressiveness of your cancer.
Make informed long-term treatment decisions with your provider using the results of the only test that can predict the risk of your cancer returning up to 15 years after initial diagnosis.
Guaranteeing That Your Results Are Accurate
Confident decision-making starts with precision medicine based on the individual.
While breast cancer is a common diagnosis, not all breast cancers are the same. By testing with EndoPredict, you and your health care provider will receive an individualized result specific to your breast cancer. EndoPredict determines the aggressiveness of your tumor by integrating its size, nodal status and gene expression to give you accurate results that are specific to you.
Your individualized result will help you understand how aggressive your cancer is, and the benefit you may get from certain treatments. It is important to know that you and your provider are making the right decisions when it comes to your treatment plan, and EndoPredict will give you the confidence that you need!
Ensuring Your Test Is Affordable
Making Your Answers Accessible
The EndoPredict report provides you with three answers to help make personalized treatment decisions with your healthcare provider about your breast cancer:
- A clear, low/high recurrence risk score for years 0-10 based on your specific tumor’s makeup.
- A result to better understand how your breast cancer will react to treatment with chemotherapy
- A result to help make long-term treatment decisions.